Comparative Effectiveness of Tocilizumab as Compared to Abatacept in Those with Prior Exposure to Anti-TNF Agents

Trial Profile

Comparative Effectiveness of Tocilizumab as Compared to Abatacept in Those with Prior Exposure to Anti-TNF Agents

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Abatacept (Primary) ; Tocilizumab (Primary) ; Tumour necrosis factor alpha inhibitors
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jun 2017 Results (n=1220) presented at the 18th Annual Congress of the European League Against Rheumatism.
    • 27 Jul 2015 New trial record
    • 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top